EUR 28.02
(-1.06%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 13.22 Million SEK | 7.06% |
2022 | 12.35 Million SEK | -23.54% |
2021 | 16.15 Million SEK | 187.3% |
2020 | 5.62 Million SEK | 0.0% |
2019 | - SEK | 0.0% |
2018 | - EUR | 0.0% |
2017 | - EUR | -100.0% |
2016 | 8.82 Million EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q3 | - SEK | 0.0% |
2024 Q1 | 10.26 Million SEK | 0.0% |
2024 Q2 | 9.02 Million EUR | 0.0% |
2023 Q3 | 8.5 Million SEK | -8.43% |
2023 Q4 | 13.22 Million SEK | 55.42% |
2023 FY | 13.22 Million SEK | 7.06% |
2023 Q2 | 9.29 Million SEK | -11.79% |
2023 Q1 | 10.53 Million SEK | 0.0% |
2022 Q4 | - SEK | 0.0% |
2022 Q1 | - EUR | 0.0% |
2022 Q2 | - EUR | 0.0% |
2022 Q3 | - EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SCHOTT Pharma AG & Co. KGaA | 69.19 Million EUR | 80.891% |
Carl Zeiss Meditec AG | 133.88 Million EUR | 90.124% |
Fielmann Aktiengesellschaft | 6.95 Million EUR | -90.108% |
Gerresheimer AG | 658.49 Million EUR | 97.992% |
Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.737% |
Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.737% |